Evidence map›Paper›PMID 29447395›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2019

Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State.

Chikara Ogimi, Janet A Englund, Miranda C Bradford, Xuan Qin, Michael Boeckh, Alpana Waghmare

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 3 pooled it
21.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 3 syntheses or guidelines pooled it, 175 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Airway disease in hematologic malignancies.Expert review of respiratory medicine · 2022
    Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chikara OgimiVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Janet A EnglundDepartment of Pediatrics, University of Washington, Seattle.
Miranda C BradfordChildren's Core for Biomedical Statistics, Center for Clinical and Translational Research, Seattle Children's Research Institute, Washington.
Xuan QinDepartment of Laboratory Medicine, University of Washington, Seattle.
Michael BoeckhVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Alpana WaghmareVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Seattle Children's Hospital · USSeattle Children's Hospital · USFred Hutch Cancer Center · USUniversity of Washington · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
Respiratory Viruses and Airflow Obstruction after HCTR01HL081595 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2005 to 2008
$2.5M
Infections in Hematopoietic Cell Transplant RecipientsK24HL093294 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2009 to 2019
$1.5M
Viral and Host Biomarkers of Human Rhinovirus Disease Severity in TransplantationK23AI114844 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI WAGHMARE, ALPANA AMALKANT · 2015 to 2019
$897k
NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR002319NHLBI NIH HHS K24 HL093294NHLBI NIH HHS R01 HL081595NIAID NIH HHS K23 AI114844
6 · The paper itself

Abstract

backgroundImmunocompromised children might be predisposed to serious infections from human coronaviruses (HCoVs), including strains OC43, NL63, HKU1, and 229E; however, the virologic and clinical features of HCoV infection in immunocompromised children have not been compared to those in nonimmunocompromised children.

methodsWe retrospectively analyzed a cohort of children who presented to Seattle Children's Hospital and in whom HCoV was detected by a multiplex respiratory polymerase chain reaction assay of a nasal sample between October 2012 and March 2016. Lower respiratory tract disease (LRTD) was defined as possible or definite infiltrate seen in chest imaging, need for oxygen, or abnormal lung examination in conjunction with a physician diagnosis of LRTD. We used logistic regression modeling to evaluate risk factors for LRTD and LRTD that necessitated oxygen use (severe LRTD), including an immunocompromised state, in children with HCoV infection.

resultsThe median ages of 85 immunocompromised and 1152 nonimmunocompromised children with HCoV infection were 6.3 and 1.6 years, respectively. The prevalence of LRTD and of severe LRTD did not differ greatly between the immunocompromised and nonimmunocompromised patients (22% vs 26% [LRTD] and 15% vs 11% [severe LRTD], respectively); however, in a multivariable model, an immunocompromised state was associated with an increased likelihood of severe LRTD (adjusted odds ratio, 2.5 [95% confidence interval, 1.2-4.9]; P = .01). Younger age, having an underlying pulmonary disorder, and the presence of respiratory syncytial virus were also associated with LRTD or severe LRTD in multivariable models. The risks of LRTD or severe LRTD did not differ among the children with different HCoV strains.

conclusionsThe presence of a copathogen and host factors, including an immunocompromised state, were associated with increased risk for severe LRTD. Recognizing risk factors for severe respiratory illness might assist in risk stratification.

Indexed as

Immunocompromised HostAge FactorsChildChild, PreschoolCoinfectionCoronavirus InfectionsFemaleHumansInfantMaleRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsRetrospective StudiesRisk FactorsSeasonsSeverity of Illness Indexhuman coronavirusimmunocompromised hostlower respiratory tract diseaserespiratory copathogenrespiratory polymerase chain reaction (PCR)

Identifiers

PMID29447395
PMCPMC6437838
OpenAlexW2789557373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.